From breast cancer to HIV, how AI is set to revolutionise healthcare
Among the AI projects being showcased beneath the glass roof of the Grand Palais is a robot that could help to break down barriers in healthcare.
"Our AI will provide practical, tailored answers to questions about sexual health and HIV prevention, which are still very taboo subjects. Our users can ask all the questions they want, and our AI will guide them through self-testing and, if necessary, put them in touch anonymously with clinicians," said Sarah Morris, marketing manager for South African-American company Audere, which produces this robot.
Why the African continent has a role to play in developing AI
While this week's AI Action Summit in Paris is a showcase for future developments in the sphere, AI is already being used to support healthcare professionals.
Read more on RFI English
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
41 minutes ago
- Health Line
What Is Rupioid Psoriasis?
Rupioid psoriasis is a type of psoriasis that causes thick plaques that may resemble barnacles or oyster shells. It's rare, but it may cause severe symptoms for some people. Psoriasis is an autoimmune disease that causes rashes that are often itchy and scaly. The most common type, plaque psoriasis, is characterized by raised and red patches of skin. Rupioid psoriasis is a type of plaque psoriasis. Some people with rupioid psoriasis develop severely itchy or painful plaques that can cover large areas of the body, such as the back or limbs. Due to the thickness of the plaques, it can be challenging to treat with creams, but many people have relief with medications taken in other ways, such as injections. Learn more about rupioid psoriasis, such as potential causes, symptoms, and treatment options. Rupioid psoriasis causes and risk factors Rupioid psoriasis is a rare type of plaque psoriasis. It's frequently associated with immunosuppressive conditions like HIV. Doctors don't know the exact cause of plaque psoriasis, but it's thought to develop when your immune system starts attacking healthy skin cells. This autoimmune reaction can cause inflammation and the formation of plaques. Rupioid psoriasis seems to occur more frequently in males than females and is particularly rare among children. Psoriasis is thought to develop due to a combination of factors, including genetics and environmental factors. People with direct family history of psoriasis seem to be more likely to develop it, too. Plaque psoriasis often develops after a previous skin injury, such as: cuts scrapes insect bites sunburns Symptoms often appear after exposure to a certain trigger. Along with skin injuries, common triggers include: stress infections frequent or excessive alcohol consumption weather changes like changes in humidity smoking alcohol sunlight some medications »MORE: These are the most common psoriasis triggers. Psoriasis and medications Psoriasis flare-ups have been linked to many types of medications, such as: beta-blockers antimalarial drugs bupropion calcium channel blockers captopril fluoxetine lithium penicillin terbinafine interferons interleukins fluoxetine glyburide granulocyte colony-stimulating factor Rupioid psoriasis symptoms Rupioud psoriasis and other forms of plaque psoriasis cause raised plaques of skin that usually have a silvery and crusted layer over them. Unlike other forms of plaque psoriasis, the characteristic sign of rupioid psoriasis is thick and crusty plaques that resemble oyster shells or barnacles. Plaques may also: cause pinpoint bleeding when the area is scraped (Auspitz sign) be a darker color than plaques caused by other types of psoriasis have well-defined borders Plaques can occur anywhere, but often occur on your: torso scalp knees elbows arms legs Rupioid psoriasis pictures Here are some examples of rupioid psoriasis. Note the barnacle or oyster shell-like appearance of the plaques. Potential complications of rupioid psoriasis People with rupioid psoriasis seem to be particularly prone to developing a complication called psoriatic arthritis. Psoriatic arthritis can cause symptoms like: joint pain and tenderness swollen joints joint stiffness reduced range of motion warmth in your joints People with psoriasis may also be at an increased risk of developing some other conditions, such as: cardiovascular disease eye inflammation (uveitis) some other autoimmune conditions »MORE: These are the potential complications of psoriasis. When to get medical help It's important to seek medical help if you develop potential symptoms of psoriasis, such as unexplained rashes or itchiness. It's also important to visit your doctor if you've previously been diagnosed but you develop new or worsening symptoms. Your doctor can recommend how to reduce your symptoms and tell you if you may benefit from treatments like prescription medications to reduce your symptoms. »FIND CARE: Find a dermatologist in your area today. Rupioid psoriasis diagnosis The initial step to getting a psoriasis diagnosis usually involves visiting your primary healthcare professional. They will ask you questions about your symptoms, review your medical history, and examine your skin during your initial appointment. They may highly suspect psoriasis based on the appearance of your plaques. To confirm the diagnosis, they may take a small sample of your skin called a biopsy so that it can be examined under a microscope. They may refer you to a doctor who specializes in conditions of the skin and hair, called a dermatologist. Rupioid psoriasis treatment The best treatment for you depends on the severity of your symptoms. Your doctor may suggest trying medicated anti-inflammatory creams. However, rupioid psoriasis can be particularly hard to treat with topical options because the thick plaques may make it difficult for them to penetrate your skin. Your doctor may prescribe oral medications or medications administered through injection in combination with topical medications to reduce immune system activity. These medications may include: methotrexate cyclosporine ustekinumab steroids Can you prevent rupioid psoriasis? It's not always possible to prevent psoriasis, but you may be able to reduce your number of flare-ups by avoiding your triggers. Many people find it helpful to carry a journal or keep a list on their phone tracking when their flare-ups occurred and which factors might have contributed. Living with rupioid psoriasis Psoriasis doesn't have a cure, but receiving proper treatment can help you keep your symptoms under control. Psoriasis often comes in flare-ups. Identifying your triggers and figuring out when your symptoms get worse is important for anybody living with psoriasis. You may have to try several treatment options before you find one that's effective for you. But many people are eventually able to keep their symptoms under control. Takeaway Rupioid psoriasis is a rare but often severe form of psoriasis that causes plaques that may resemble oyster shells or barnacles. These plaques can become very itchy or painful. It's important to speak with a doctor if you think you may have psoriasis or if you think your psoriasis is getting worse. They may recommend trying treatment options like prescription creams or medications administered through injections.
Yahoo
an hour ago
- Yahoo
Mistral in talks with VC firms, MGX to raise funds at $10 billion valuation, FT reports
(Reuters) -French artificial intelligence startup Mistral is in talks with investors, venture capital firms and Abu Dhabi's MGX to raise $1 billion at a valuation of $10 billion, the Financial Times reported on Friday, citing people familiar with the matter. The company launched in June Europe's first AI reasoning model, which uses logical thinking to create a response, as it tries to keep pace with American and Chinese rivals at the forefront of AI development. The funding would accelerate the commercial rollout of Mistral's Le Chat chatbot and support continued development of its large language models, the report said. MGX and Mistral did not immediately respond to Reuters requests for comment. The startup raised 600 million euros in a Series B funding round that valued the company at 5.8 billion euros last year. Industry observers consider Mistral as Europe's best-positioned AI company to rival Silicon Valley leaders, though the French firm has yet to achieve comparable market traction or revenue scale. Mistral counts Nvidia, Andreessen Horowitz and Lightspeed Venture Partners among its investors. Sign in to access your portfolio
an hour ago
Multiple medical groups say they have been barred from work on CDC's panel of vaccine advisers
Multiple medical groups say they have been barred from working on the Centers for Disease Control and Prevention's panel of vaccine advisers. It comes weeks after Health and Human Services Secretary Robert F. Kennedy Jr. fired the original panel of independent experts and replaced them with his own handpicked members -- many of whom have expressed skeptical views on vaccines. Liaisons representing major medical groups were historically invited to meetings of the Advisory Committee on Immunization Practices (ACIP) as non-voting members to provide their independent expertise in respective fields. In a joint statement, the groups said they have now been excluded "from the process of reviewing scientific evidence end informing vaccine recommendations." A total of eight groups signed on to the statement, including the American Academy of Pediatrics, teh American College of Physicians, the American Medical Association and the National Medical Association among others. In a statement provided to ABC News, an HHS spokesperson said: "Under the old ACIP, outside pressure to align with vaccine orthodoxy limited asking the hard questions. The old ACIP members were plagued by conflicts of interest, influence, and bias. We are fulfilling our promise to the American people to never again allow those conflicts to taint vaccine recommendations." The statement went on to say: "Experts will continue to be included based on relevant experience and expertise, not because of what organization they are with." In their statement, the medical organizations said they learned the groups will be excluded from the panel's work in an email late Thursday and noted they were "deeply disappointed and alarmed" by the move. "To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines," the statement read.
